Platinumone Bus. (543352)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 13.72% indicates adequate capital efficiency.
• Dividend yield of 1.38% provides a modest income cushion.
• Latest quarter net margin of ~6.7% (₹1 Cr profit on ₹15 Cr sales) shows some earnings capability.
• Stock has held within a 52-week range of ₹109–₹170, suggesting some buyer support.

Concerns

• Sales growth is negative at -2.12%, showing shrinking top line.
• Profit growth has collapsed by -51.77%, severely eroding earning power.
• Piotroski F-Score of 3/9 signals weak financial health and potential operational deterioration.
• P/E of 27.64 is excessive for a declining, microcap BPO/KPO business.

AI Analysis

At ₹152 with a market cap of just ₹26 crore, Platinumone is a microcap. I always ask what the business will earn over time. The latest quarter shows ₹15 crore sales and ₹1 crore net profit, but the trailing P/E of 27.64 implies annual earnings under ₹1 crore. That is not cheap for a company whose sales fell 2.12% and whose profit collapsed 51.77%. A Piotroski F-score of 3 out of 9 is a red flag—it suggests deteriorating operating efficiency, leverage, or asset utilisation. I see no economic moat in BPO/KPO, where competition and client concentration are brutal. ROCE of 13.72% is respectable, and the 1.38% dividend shows some cash discipline, but the small base makes this fragile. Benjamin Graham would demand a margin of safety; here, earning power is shrinking, yet the market still values the company at over 27 times weak profits. Unless the business reverses course and restores growth, the multiple will compress. I need evidence before investing: stable quarterly sales, recovery in net profit, and a healthier F-score. Right now, this is a slow grower at best—or a value trap in the making. I would not touch it without a much lower price, perhaps near the 52-week low of ₹109, and even then I’d demand full balance-sheet details. With no data on book value, debt, or promoter holding, I am flying blind. If profits have truly halved, the P/E is optically misleading. Patience beats buying a microcap with worsening fundamentals. I will keep it on my watchlist, not in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer